Using an Internet Study to Improve Adherence for Psoriasis Patients

Inclusion Criteria:

Any male or female 18 years or older of age with a diagnosis of mild to moderate psoriasis by a dermatologist will be eligible for participation.
Less than 20% of body surface involvement for psoriasis.
Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed.
The subject is able to complete the study and comply with study instructions, including attending all study visits.
In general good health with no other skin disease, disease state or physical condition which would impair evaluation of psoriasis or which would increase health risk by study participation

Exclusion Criteria:

Individuals younger than 18 years of age.
Known allergy or sensitivity to topical fluocinonide.
Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
Introduction of any other prescription medication, topical or systemic, for psoriasis while participating in the study. Subjects who are on systemic anti-inflammatory treatments for psoriasis must be on a stable dose for at least 3 months prior to enrollment.
Any skin condition or disease that may require concurrent therapy or may confound evaluations
Current enrollment in any research study involving an investigational drug